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INTRODUCTION
In the mammalian central nervous system 
(CNS), neurogenesis occurs mainly prenatally but 
continues in restricted regions during the postnatal 
life. It is intensive during the first two weeks after 
birth picking at P7-P9. Thereafter, neurogenesis is 
significantly diminished and remains longlife in the 
subventricular zone (SVZ) of the lateral ventricle 
and the subgranular zone (SGZ) of the dentate gyrus 
(DG) (3,13). Actually, adult neurogenesis repeats in a 
similar way the stages of generation and functional 
integration of new neurons like the developing brain. 
Therefore, data on early postnatal neurogenensis may 
be helpful to elucidate basic neurogenic mechanisms 
in the adult brain.
The use of the thymidine analog BrdU has 
become a valuable tool for studying neurogenesis 
in the adult mammalian brain, including in human 
(6,8,11). BrdU immunohistochemistry is currently 
the most used technique for birth dating and cell 
proliferation monitoring that is one of the most 
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PURPOSES: We applied the thymidine analog, 5-bromo-2’-deoxyuridine (BrdU), that labels DNA to study 
neurogenic events in many brain regions of the postnatal mammalian brain and to evaluate its paradigms, 
pitfalls and limitations.
MATERIAL AND METHODS: Different BrdU paradigms and various time points between postnatal day 
P0 and P51 were applied to Wistar rats. Paraffin sections for single or double BrdU immunohistochemis-
try combined with neuronal markers nestin, Dcx, MAP(2) and NeuN by peroxidase or fluorescence labeling 
were examined. Sections were analyzed using standard or confocal microscopy and stereology.
RESULTS: Peak neurogenesis was found out in the dentate gyrus during the first postnatal week of life with 
a progressive decline after P9. Areas with substantial neurogenesis such as subventricular zone of the later-
al ventricles, subgranular zone of the hippocampal dentate gyrus, and cerebellum were observed. By P14 to 
P18, cell proliferation was reduced in most brain areas with exception of the dentate gyrus. Numerical den-
sities of BrdU(+) cells in all evaluated brain regions were higher in the younger animals and decreased with 
age. Most newly-enerated cells became nonneuronal cells (endothelial and glial cells). BrdU colocalization 
with neuronal markers was rarely found out mainly within the dentate gyrus and cerebellum.
CONCLUSION: In the developing rat brain, BrdU labeling showed regional distribution. It was dose-, age- 
and survival time-dependent. Our findings provided useful information on BrdU application in the study 
of postnatal neurogenesis.
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important processes involved in CNS development 
(1,10,15). However, the use of BrdU for studying 
neurogenesis is not without pitfalls and limitations. 
As a thymidine analog, BrdU is a marker of DNA 
synthesis and not a marker of the S-phase of the cell 
cycle. Moreover, BrdU is a toxic substance that alters 
DNA stability, lengthens the cell cycle and triggers 
cell death. It also has mitogenic, transcriptional and 
translational effects with profound consequences on 
neurogenesis (7,12,13). Therefore, the application of 
BrdU requires distinguishing the cell proliferation 
from other processes involving DNA synthesiss such 
as DNA repair, gene duplication and abortive cell 
cycle reentry.
The goal of this investigation was to provide 
additional information on BrdU application in the 
study of early postnatal neurogenic events that may 
give better insights into adult neurogenesis.
MATERIAL AND METHODS
All animal experiments were performed in 
accordance to the institutional guidelines. Wistar 
rats (BgVV, Berlin) were injected with BrdU (Sigma, 
St. Louis, MO) using different paradigms (see Fig. 
1). Animals were anesthetized and transcardially 
perfused with 0,01M PBS, followed by 4% 
paraformaldehyde in 0,1M PB. All brains were 
removed and postfixed in the same fixative. Paraffin 
sections were processed for standard single or double 
immunolabeling for peroxidase or fluorescence 
staining. First antibodies against BrdU, Nestin, 
Doublecortin (Dcx), MAP(2) and NeuN followed by 
corresponding biotinylated second antibodies, ABC 
reagent and DAB/VNR substrate were applied. By 
fluorescence labeling, Alexa Fluor 594 or 488 and 
Vectashield mounting medium with DAPI were used. 
Microscopic analysis of the stained sections was done 
and digital images were taken. Morphometric counts 
evaluating BrdU(+) nuclei by peroxidase labeling on 
P9, P12, P15 and P23 or Dcx(+) cells, BrdU(+) nuclei 
and Dcx(+)/BrdU(+) colocalization on P15 using 
confocal images were done in a blinded fashion. 
Values were presented as mean ±S.E.M.
RESULTS
We have examined intensity and distribution 
of BrdU immunostaining in rat brains by different 
paradigms. By same dosage, longer survival times 
Fig. 1. Six main BrdU paradigms were used in this study. Animals on P0 to P30 were distributed into 26 groups (n=3-
9 per group) and daily injected with 50 or 100 mg/kg BrdU i.p. one or more days. Perfusion was performed at various 
survival times between 1 to 28 days
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showed a reduced staining. In our pilot experiment, 
we have found out that a less intensive BrdU staining 
was present by lower dosages of BrdU when survival 
times were equal. Younger animals showed more 
expressed BrdU positivity in all ten regions examined 
from various parts of the brain such as frontal 
and parietal cortices, caudate, thalamus, DG and 
cerebellum. A very dense staining was detected in 
many cells of PVZ which were directed by the rostral 
migratory stream (RMS) into the olfactory bulb, as 
well as in SGZ of DG and cerebellum (Fig. 2). At the 
end of the second postnatal week, BrdU expression 
was restricted mainly to two regions, i.e., the SVZ of 
the lateral ventricle and SGZ of DG. 
Summarized total proliferative scores of 
BrdU(+) cell countings in ten brain regions at P9, P12, 
P15 and P23 demonstrated a significant decrease 
compared to each previous age group (Fig. 3B), the 
respective BrdU paradigms were presented in Fig. 
3A. We quantified Dcx, BrdU, Dcx/BrdU immuno(+) 
cells in rat DG on P15 (fig. 3C). We found that 77,87% 
of BrdU(+) nuclei were located in Dcx(+) cells and 
more than one half of Dcx(+) cells, i.e., 51,04% were 
positive for BrdU. 
Frequent colocalization for BrdU(+)/Nestin(+) 
or BrdU(+)/Dcx(+) was found in specific regions 
such as the SVZ, cerebellum, corpus callosum and 
DG-SGZ (data not shown). BrdU(+)/MAP(2)(+) 
and BrdU(+)/NeuN(+) colocalizations were seen by 
later timings. During the first two postnatal weeks, 
Nestin(+) radial glia and Dcx(+) cells underwent 
a considerable reduction in number. MAP(2) and 
NeuN immunoexpression increased after P9 and 
remained constant in older animals.
Fig. 2. Micrographs showing a partial sagittal view of a rat brain on P7 after one 100 mg/kg BrdU injection on P6. An 
intense immuno(+) staining for BrdU is detected in PVZ of the lateral ventricle, RMS, SGZ of DG and cerebellar cortex. 
Indirect peroxidase immunohistochemistry for BrdU (VNR substrate) and hematoxylin counterstaining
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DISCUSSION 
As it has been demonstrated in our study 
of the developing rat brain, cell proliferation as 
expressed by BrdU immuno(+) nuclei and neuronal 
differentiation as manifested by neuronal markers 
such as Dcx, MAP(2) and NeuN display regional 
distribution and age dependency. BrdU labeling also 
shows dose and survival time dependency. Reduction 
in number of Nestin(+) and Dcx cells(+), especially 
for nestin(+) radial glia in neocortex, together with 
an increasing expression of MAP(2) and NeuN are 
indicative of neuronal migration and differentiation 
that are still going on during the early postnatal 
period. Most newly-generated cells in the rat brain 
become nonneuronal cells (endothelial and glial 
cells). Our findings on the colocalization of BrdU 
and Dcx markers in DG on P15 indicate that a higher 
percentage of the newly-generated cells, i.e., 77,87% 
of all BrdU(+) cells in that particular brain region are 
positive for Dcx marker and represent young neurons. 
The remaining lower percentage (22,13%) of BrdU(+) 
cells negative for Dcx are evidently nonneural cells 
or, eventually, neural cells in a different phase of their 
development which do not express any Dcx marker. 
The Dcx(+)/BrdU(-) cells that represent 48,96% of all 
Dcx(+) in DG are obviously generated before P6, the 
first day of BrdU application for P15 paradigm or 
they may contain a nondetectable amount of BrdU at 
the moment of perfusion.
We establish that after the first two weeks, 
postnatal neurogenesis in the rat is considerably 
reduced and restricted to two brain regions: the SVZ 
of the lateral ventricle and SGZ of the DG. In both 
zones a small pool of multipotent neural precursors 
remain lifelong and may contribute to repair 
following CNS disorders (9,13).
BrdU application should be conducted with 
appropriate controls and combined with other 
relevant tools and techniques for studying the 
neurogenesis (1,2,4). It requires careful interpretation 
of the data and comparison with alternative methods 
of investigation such as proliferative markers, 14C 
labeling, retroviral labeling etc. (3,5,14).
CONCLUSIONS
Early postnatal neurogenesis in the rat brain 
continues at a high rate during the first two weeks. 
Thereafter, it is significantly reduced and remains 
at a low rate in the SVZ of the lateral ventricle 
and SGZ of the hippocampal formation. BrdU 
immunohistochemistry is a valuable and reliable 
assay for studying the postnatal neurogenesis despite 
some restrictions and pitfalls.
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Fig. 3. A) BrdU paradigms for P9, P12, P15 and P23. B) 
BrdU(+) cell counts in rat brain on P9, P12, P15 and P23 
(n=5 for each group). Student’s t-test, ***P<0.001, when 
compared with each of the previous time point scores. 
C) Dcx, BrdU, Dcx/BrdU immuno(+) cell counts in rat 
DG of P15 group (n=5)
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